Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptamer GroupFRA:P0J Market Cap is €18.18 Mil as of Jul. 29, 2026. The stock has 4 warning signs investors should review. Among 1,421 Biotechnology companies, Aptamer Group ranks worse than 75.3% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aptamer Group's share price for the quarter that ended in Dec. 2025 was €0.01. Aptamer Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 2,927.06 Mil. Therefore, Aptamer Group's market cap for the quarter that ended in Dec. 2025 was €29.27 Mil.
Aptamer Group's quarterly market cap
declined
from Dec. 2024 (€3.98 Mil) to Jun. 2025 (€1.00 Mil) but then
increased
from Jun. 2025 (€1.00 Mil) to Dec. 2025 (€29.27 Mil).
Aptamer Group's annual market cap
declined
from Jun. 2023 (€4.21 Mil) to Jun. 2024 (€3.27 Mil) and
declined
from Jun. 2024 (€3.27 Mil) to Jun. 2025 (€1.00 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aptamer Group's Enterprise Value for Today is €16.78 Mil.
Aptamer Group (FRA:P0J) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Aptamer Group Market Cap Related Terms
Aptamer Group Market Cap Historical Data
* Premium members only.
The historical data trend for Aptamer Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:P0J vs VRTX, REGN, RVMD: Market Cap Comparison
For the Biotechnology subindustry, Aptamer Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptamer Group Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aptamer Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Aptamer Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Aptamer Group's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptamer Group (FRA:P0J) has a Market Cap of €18.18 Mil as of Jul. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aptamer Group and its competitors. According to the industry distribution chart, Aptamer Group ranks #1070 out of 1421 companies in the Biotechnology industry, placing it in the top 75.3%.
Is Aptamer Group's Market Cap too high?
Aptamer Group's current Market Cap is €18.18 Mil. Based on the distribution chart, Aptamer Group ranks #1070 out of 1421 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Aptamer Group's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aptamer Group ranks #1070 out of 1421 companies for Market Cap. This places Aptamer Group in the lower half of its industry. The industry median Market Cap is 111.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 111.82, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aptamer Group and its competitors. For the Biotechnology industry, the median Market Cap is 111.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptamer Group's current Market Cap is €18.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptamer Group stock overvalued right now?
Aptamer Group (FRA:P0J) has a current Market Cap of €18.18 Mil. The current Market Cap is €18.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Aptamer Group (FRA:P0J), the current Market Cap is €18.18 Mil as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses, Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:P0J has been successfully added to your 
